Inhibition of Dendritic Cell Differentiation by Fumaric Acid Esters
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (2), 203-208
- https://doi.org/10.1046/j.1523-1747.2001.01159.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- How can dendritic cells cause autoimmune disease?Immunology Today, 2000
- Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic useBritish Journal of Dermatology, 1999
- Treatment of Psoriasis with Interleukin-10Journal of Investigative Dermatology, 1998
- The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine networkBritish Journal of Dermatology, 1998
- Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Journal of Clinical Investigation, 1998
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer Antigen Processing and Presentation Chimpanzee Dendritic Cells Derived In Vitro from Blood Monocytes and Pulsed with Antigen Elicit Specific Immune Responses In VivoJournal of Immunotherapy, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Antipsoriatic effect of fumaric acid derivativesJournal of the American Academy of Dermatology, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994